Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001125282-05-005002
Filing Date
2005-09-29
Accepted
2005-09-29 06:03:37
Documents
14
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 b408915_10k.txt 10-K 540391
2 EXHIBIT 10.32 b408915_ex10-32.txt EX-10 17955
3 EXHIBIT 10.33 b408915_ex10-33.txt EX-10 58736
4 EXHIBIT 10.34 b408915_ex10-34.txt EX-10 5514
5 EXHIBIT 10.35 b408915_ex10-35.txt EX-10 12336
6 EXHIBIT 10.36 b408915_ex10-36.txt EX-10 29210
7 EXHIBIT 10.37 b408915_ex10-37.txt EX-10 29179
8 EXHIBIT 10.38 b408915_ex10-38.txt EX-10.38 3096
9 EXHIBIT 12.1 b408915_ex12-1.txt EX-12 2681
10 EXHIBIT 23 b408915_ex-23.txt EX-23 4269
11 EXHIBIT 31.1 b408915_ex31-1.txt EX-31 5507
12 EXHIBIT 31.2 b408915_ex31-2.txt EX-31 5601
13 EXHIBIT 32.1 b408915_ex32-1.txt EX-32 1858
14 EXHIBIT 32.2 b408915_ex32-2.txt EX-32 1973
  Complete submission text file 0001125282-05-005002.txt   719994
Mailing Address C/O DORSEY & WHITNEY LLP 250 PARK AVE NEW YORK NY 10177
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 7329804500
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12957 | Film No.: 051109709
SIC: 2836 Biological Products, (No Diagnostic Substances)